Blog - Page 3866 of 5174

MondayNov 03, 2008 4:21 am

NGAS Resources, Inc. (NASDAQ: NGAS)

NGAS Resources, Inc. (NASDAQ: NGAS), an independent exploration and production company, has focused its operations primarily on the Appalachian Basin. The company generates its own geological prospects in this region and has strategically structured its business to achieve capital appreciation through growth in natural gas reserves, production, and cash flow. NGAS has the competitive advantage of acquiring nearby acreage not yet developed. For further information, visit the Company's web site at www.ngas.com.

MondayNov 03, 2008 4:21 am

New Guinea Gold Corporation (TSX:NGG CN)

New Guinea Gold Corporation (TSX: NGG CN), the premier junior explorer and miner in Papua New Guinea, has direct and indirect interests in twelve properties. With 75,000 + metres of drilling completed, extensive gold or copper-gold-molybdenum mineralization has been discovered at 11 of the properties while the 12th contains widespread and extensive alluvial gold. The company’s Sinivit mine is anticipated to generate cash flow for on-going exploration of other large scale targets. For further information, visit the Company's web site at www.newguineagold.ca.

MondayNov 03, 2008 4:20 am

Nevsun Resources, Ltd. (AMEX: NSU)

Nevsun Resources, Ltd. (AMEX: NSU), a gold and base metal explorer/developer, is focused on developing mining projects in Africa. Currently, the company is dedicating its efforts to advancing its high grade gold, copper and zinc Bisha Project in Eritrea. A feasibility study for this project was completed in 2006. Nevsun’s mining license covers an area of 16.5 square kilometers (includes the Bisha Main Zone deposit and the Northwest Zone deposit) within a mining agreement area of approximately 39 square kilometers. For further information, visit the Company's web site at www.nevsun.com.

MondayNov 03, 2008 4:20 am

NeurogesX, Inc. (NASDAQ: NTII)

NeurogesX, Inc. (NASDAQ: NGSX), a biopharmaceutical company based in the San Francisco Bay Area, is focused on developing effective treatments that relieve chronic pain and improve quality of life. NGX-4010, the company’s leading product candidate, could possibly revolutionize the treatment of neuropathic pain as a single application may provide months of relief. The product candidate is currently in Phase 3 clinical trials. For further information, visit the Company's web site at www.neurogesx.com

MondayNov 03, 2008 4:19 am

Arcade Acquisition Corporation (OTC BB: ACDQ)

Arcade Acquisition Corporation (OTC BB: ACDQ) is a private investment partnership that invests in middle-market leveraged buy-out and recapitalization transactions. Arcade gained national recognition for prior investments such as American Cellular Corporation and BoxUSA Inc. Led by their three principals John Chapman, Jonathan Furer and Muhit Rahman, Arcade Acquisition is well-placed for the future. For further information, visit the company website at: www.arcadepartners.com.

MondayNov 03, 2008 4:19 am

Neurobiological Technologies, Inc. (NASDAQ: NTII)

Neurobiological Technologies, Inc. (NASDAQ: NTII), a biotechnology company, has their focus on acquiring and developing central nervous system (CNS) related drug candidates. The company strategically in-licenses late-stage CNS agents and then pursues regulatory approval and commercialization. Neurobiological’s goal as a company is to develop and market drug candidates in the United States, Europe and Asia while possibly seeking partnerships with pharmaceutical and biotechnology companies. For further information, visit the Company's web site at www.ntii.com.

MondayNov 03, 2008 4:18 am

Neuralstem, Inc. (AMEX: CUR)

Neuralstem, Inc. (AMEX: CUR), a publicly traded biotherapeutics company, is focused on applying stem cell research and its patented human neural stem cell technology to treat diseases of the central nervous system. The company’s patent-protected technology allows them to produce mature, commercial quantities of neural stem cells that have the capability to control the differentiation of the cells into physiologically relevant human neurons and glia. For further information, visit the Company's web site at www.neuralstem.com.

MondayNov 03, 2008 4:18 am

NetSol Technologies, Inc. (NASDAQ: NGNM)

NetSol Technologies, Inc. (NASDAQ: NTWK) is a leading global IT solutions and services provider catering to clients all over the world. While catering to the private and public sector, NetSol made national news when it was announced that Najeeb Ghauri, , chairman and chief executive officer, and Mitch Van Wye, chief operating officer, will present at the Rodman & Renshaw Annual Global Investment Conference in New York City on Monday, November 10, 2008 at the New York Palace Hotel. For further information, visit the company website at: www.netsoltek.com.

MondayNov 03, 2008 4:17 am

Neoprobe Corporation (OTC BB: NGNM)

Neoprobe Corporation (OTC BB: NEOP) has focused their efforts on developing and commercializing novel biomedical products that address the critical intraoperative, diagnostic and therapeutic treatment needs of patients and physicians. The company’s main area of dedication is on improving cancer surgery outcomes by utilizing their market-leading gamma detection devices in conjunction with radiopharmaceutical agents.

MondayNov 03, 2008 4:16 am

NeoGenomics, Inc. (OTC BB: NGNM)

NeoGenomics, Inc. (OTC BB: NGNM) is known as the only publicly-traded pure-play laboratory testing service provider that has a specific focus on high revenue cancer genetics testing. The combination of advances in technology and genetic research, with the complete sequencing of the human genome, sophisticated new scientific testing tools to diagnose and treat diseases have been made possible. The company’s two facilities in Ft. Myers, Fla., and other facilities in Nashville, Tenn. and Irvine, Calif provide state of the art genetic testing. For further information, visit the Company's web site at www.neogenomics.org.

Site Search

Company Search